lobbying_activities: 2644024
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2644024 | 2a9710b8-16ad-41e1-9152-67cad8c2d2b5 | Q2 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 401104864 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 2021 | second_quarter | INS | Discussions with Congressional offices regarding prescriber education in conjunction with the Comprehensive Addiction Recovery Act Supported and provided technical assistance regarding the re-introduction of the Medication Access and Trainng Expansion Act of 2021 (HR 2067 / S 2235) and supported its simultaneous passage with the Mainstreaming Addiction Treatment Act of 2021 (HR 1384) Suggested grant eligibility and Medicaid and Medicare related changes regarding provider reimbursement bump and substance use disorder coverage in conjunction with the possible reintroduction of the CARE Act of 2021. Supported passage of the Medicaid Reentry Act (HR 955/S 285) and its inclusion in the next reconcillation package Discussion with ONDCP staff regarding drug policy priorities in 2021 Advocated for creation of a new safe harbor provision to the Federal Anti-Kickback Statute to protect the use of cash and cash-equivalent payments offered as part of contingency management in the treatment of substance use disorders Advocated for increased FY 22 appropriations for HRSA's Mental Health and Substance Use Disorders Training Demonstration program, SAMHSA's expansion of practitioner education grant program, and HRSA's Substance Use Disorder (SUD) Workforce Loan Repayment Program, among other SUD-related appropriation increases in conjunction with other coalitions Supported the Resident Physician Shortage Reduction Act, which would increase the number of Medicare GME slots by 14,000 over 7 years, including its inclusion in the next reconcillation package Advocated for changes to a draft opioid treatment program bill to make permanent certain COVID-19 flexibilities allowed to states for unsupervised doses, as well as "time in treatment" regulatory changes and to permit pharmacy dispensing of methadone for opioid use disorder treatment for certain experienced cohorts of prescribers Sent a letter with other stakeholders to leaders of the Senate and House Appropriations Subcommittees on Labor, HHS, Education, and Related Agencies outlining appropriations recommendations for FY22. These recommendations include maintaining or increasing funding for a broad range of prevention, treatment, harm reduction, and recovery support programs vital to combatting the nations addiction crisis. Provided comments on draft legislation that would expand addiction treatment in jails and prisons As part of MHLG coalition, submitted a letter in support of the Parity Enforcement Act (H.R. 1364), which would give the U.S. Department of Labor (USDOL) a critical tool to ensure health plan compliance with the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (Federal Parity Act). Supported the reintroduction of the Opioid Workforce Act, which would expand the physician workforce by providing support for 1,000 new graduate medical education training positions over five years in hospitals that have-or are in the process of establishing-accredited residency programs in addiction medicine, addiction psychiatry, or pain medicine. Sent a letter with other stakeholders urging FDA to propose and finalize regulations expeditiously to implement a proposal that would ban menthol and flavored cigarettes, which would protect youth against tobacco use initiation, reduce health disparities, and save lives. Sent a letter to the U.S. Department of Health and Human Services (HHS) to provide comments on the proposed modifications to the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule, intended to support, and remove barriers to, coordinated care and individual engagement. Sent a letter with other stakeholders in support of the Excellence in Recovery Housing Act, which would greatly improve our nations understanding of the quality, effectiveness, and availability of recovery housing; better coordinate the federal governments efforts in this regard, and help create guidelines for states to promote the availability of high-quality recovery housing. Participated in a call with SAMHSA to discuss ASAM Criteria resources and trainings for states. Sent a letter with other stakeholders urging legislators to include $120 million for the Infectious Diseases and the Opioid Epidemic program in the Senate and House Appropriations Subcommittees on Labor, Health and Human Services, Education, and Related Agencies' appropriations bills. Sent a letter in support of H.R. 2503, the Social Determinants Accelerator Act of 2021, which would create an inter-agency technical advisory council on social determinants of health (SDOH) and a new federal grant program to assist state, local, and Tribal governments in tackling persistent economic and social conditions that impact the prevention and treatment of chronic medical conditions, including addiction. ASAM submitted comments in response to a section of a proposed rule from the Centers for Medicare and Medicaid Services (CMS) intended to implement a provision of the Consolidated Appropriations Act of 2021 which created 1,000 additional Medicare-supported graduate medical education (GME) positions. Sent a letter with other stakeholders to CMS advocating for alternative payment models designed by practicing physicians to enable CMMI to accelerate value-based payment and care delivery for patients with Medicare and Medicaid. Sent letter with other stakeholders to Senators in support for the nomination of Dr. Miriam E. Delphin-Rittmon for Assistant Secretary for Mental Health and Substance Use at the U.S. Department of Health and Human Services. Sent letters with other stakeholders in support of legislation (S 2043 / House companion bill) to make Veterans Health Administration (VHA) facilities fully smoke-free. As part of the MHLG coalition, sent letter to bill sponsors in support for H.R. 3450/S. 1727, the Medicaid Bump Act, which would incentivize states to expand coverage of behavioral health services, including mental health and substance use services, by providing a corresponding increase in the Federal Medical Assistance Percentage (FMAP) matching rate to 90% for these services As part of the MHLG coalition, sent letter to Senate sponsors in support for the Excellence in Mental Health and Addiction Treatment Expansion Act (S. 2069), which would allow for every state and territory the ability to join the Certified Community Behavioral Health Clinic (CCBHC) demonstration and would authorize investments in the model for current and prospective CCBHCs. Advocated draft House bill legislation regarding a permanent repeal of the IMD exclusion Advocated for new legisaltion to close coverage caps in Medicare related to substance use disorder facilities and services | Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 70000 | 0 | 0 | 2021-07-19T06:46:19.687000-04:00 |